Influence of histopathological changes after neoadjuvant chemotherapy on the survival of breast cancer patients
Sabine Danzinger(Medical University of Vienna), Michael Seifert(Zimmer Biomet (Germany)), Kristina Tendl-Schulz(Medical University of Vienna), Hannes Vietzen(Medical University of Vienna), Verena Heiss Spornberger(Medical University of Vienna), Georg Pfeiler(Medical University of Vienna), Christian F. Singer(Medical University of Vienna)
Cited by 2
Related Papers
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2021|255
Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis
|Cell|2023|170
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
|New England Journal of Medicine|2024|151
Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19
|Genetics in Medicine|2021|138